Vaso Corp Share Price Other OTC
Equities
US9223211049
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
01/04 | Vaso Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
01/04 | Vaso Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Sales 2022 | 80.02M 6.67B | Sales 2023 | 81.02M 6.76B | Capitalization | 53.47M 4.46B |
---|---|---|---|---|---|
Net income 2022 | 11M 917M | Net income 2023 | 4M 334M | EV / Sales 2022 | 0.13 x |
Net cash position 2022 | 18.52M 1.54B | Net cash position 2023 | 23.26M 1.94B | EV / Sales 2023 | 0.37 x |
P/E ratio 2022 |
2.41
x | P/E ratio 2023 |
11.1
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 52.4% |
Managers | Title | Age | Since |
---|---|---|---|
Jun Ma
CEO | Chief Executive Officer | 60 | 01/07/01 |
Jonathan Newton
DFI | Director of Finance/CFO | 63 | 01/10/01 |
Michael Beecher
DFI | Director of Finance/CFO | 79 | 21/11/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Castle
COO | Chief Operating Officer | 55 | 19/10/19 |
Jun Ma
CEO | Chief Executive Officer | 60 | 01/07/01 |
David Lieberman
BRD | Director/Board Member | 79 | 28/11/28 |
1st Jan change | Capi. | |
---|---|---|
+8.71% | 219B | |
+7.12% | 183B | |
+10.89% | 133B | |
+25.06% | 108B | |
+0.27% | 63.06B | |
+12.75% | 52.02B | |
+3.96% | 48.2B | |
+0.32% | 40.37B | |
+13.52% | 39.35B |